Merck is making its second significant investment at the company’s Wilson plant in less than six months, a move that will boost the local economy and the site’s workforce.
Read More
More jobs and dollars for investment are coming to the Merck campus in Wilson.
Read More
Tony Copeland, North Carolina’s secretary of commerce, told a gaggle of reporters after the press conference, Durham County also offered a package of incentives to beat out rivals in Virginia and Pennsylvania.
Read More
Merck, a major New Jersey-based pharma company currently developing a vaccine against HPV, has decided to expand its facilities here in the region, investing around $650 million and creating more than 400 jobs over the next five years in Durham and Wilson. But more to the point, it’s about what kind of jobs: Manufacturing.
Read More
Drug giant Merck is expanding its presence in North Carolina with 425 new jobs headed to Durham and Wilson.
Read More
The Food and Drug Administration is looking to improve safety of the nation’s drug supply and thinks blockchain could be a help. Three of the nation’s largest firms from tech to drug development to retail will be part of the project.
Read More
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations.
Read More
